Tesamorelin
A peptide that tells the pituitary to release growth hormone. Research only. Not a protocol.
Simple words
Your pituitary is a small gland in the head. It can release growth hormone. GHRH is the peptide that says “release some.” Tesamorelin is a lab version of GHRH.
Growth hormone then tells the liver to make IGF-1. That is a growth factor in the blood. Researchers measure IGF-1 to see if the chain did anything.
What it is
A 44-amino-acid peptide. The approved medicine is Egrifta. Doctors use it for extra visceral fat (deep belly fat) in some people with HIV who have that problem from treatment. That is a specific, approved use — not a general fat shot.
What researchers studied
Julian Falutz and colleagues published a trial in the New England Journal of Medicine in 2007. People with HIV-related abdominal fat. Visceral fat went down more on tesamorelin than on placebo. IGF-1 went up. Blood sugar needed watching.
Papers
Falutz et al., 2007 — Tesamorelin and visceral fat in HIV. New England Journal of Medicine.
What this is not
Not a general weight-loss peptide like semaglutide. Not the same as CJC-1295, even though both talk to the GH system. This page does not tell you how much to take.
Related: CJC-1295